首页> Journal of clinical pharmacology.> Pharmacokinetic-Pharmacodynamic Modeling of Fostamatinib Efficacy on ACR20 to Support Dose Selection in Patients With Rheumatoid Arthritis (RA)

Pharmacokinetic-Pharmacodynamic Modeling of Fostamatinib Efficacy on ACR20 to Support Dose Selection in Patients With Rheumatoid Arthritis (RA)

导出原文传递

翻译打印收藏纠错

第一作者： Maringwa, John

作者： Maringwa, John ^[1] ; Kagedal, Matts ^[2] ; Hamren, Ulrika Wahlby ; Martin, Paul ; Cox, Eugene ; Hamren, Bengt

作者单位： Quantitat Solut BV, Breda, Netherlands ^[1] AstraZeneca Quantitat Clin Pharmacol, Sodertalje, Sweden ^[2]

关键词 ACR20 covariate effects Markov modeling mixed effects model placebo response rheumatoid arthritis serial correlation treatment effect

发布时间 2017-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Journal of clinical pharmacology.

2015年55卷3期

328-335页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览2

Journal of clinical pharmacology.

2015年55卷3期

328-335页

检索历史清除

Pharmacokinetic-Pharmacodynamic Modeling of Fostamatinib Efficacy on ACR20 to Support Dose Selection in Patients With Rheumatoid Arthritis (RA)

Journal of clinical pharmacology.

相似文献

同项目论文

Journal of clinical pharmacology.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pharmacokinetic-Pharmacodynamic Modeling of Fostamatinib Efficacy on ACR20 to Support Dose Selection in Patients With Rheumatoid Arthritis (RA)

Journal of clinical pharmacology.

相似文献

同项目论文

Journal of clinical pharmacology.

相关期刊

检索历史清除